Lin Zhao 2025 Joint Meeting of the COSA ASM and IPOS Congress

Abstracts this author is presenting:

• Patient-Derived Malignant Mesothelioma Organoids: A Novel Preclinical Platform for Personalized Treatment — Afternoon tea, Poster session 1 & Exhibition